Antibiotic Classification
Antibiotics are classified using multiple complementary systems: the WHO AWaRe framework (Access, Watch, Reserve) for stewardship purposes, first-choice versus second-choice designations for clinical selection, and traditional categorization by mechanism of action (cell wall inhibitors, protein synthesis inhibitors, nucleic acid inhibitors, membrane-active agents). 1
WHO AWaRe Framework (Primary Classification for Stewardship)
The WHO uses a traffic-light approach to categorize 257 antibiotics globally into three groups based on resistance potential and appropriate use 1:
Access Group (Green Light)
- Narrow-spectrum agents with favorable risk-benefit ratios and low resistance levels 1
- Should be widely available, affordable, and of assured quality in all healthcare facilities 1
- Recommended as empiric first- or second-choice treatment for common clinical infections 1
- Lower resistance potential compared to other groups 1
Watch Group (Orange Light)
- Broader-spectrum agents with higher resistance potential and greater toxicity concerns 1
- Includes highest priority critically important antimicrobials such as fluoroquinolones and carbapenems 1
- Should be key targets of antimicrobial stewardship and monitoring programs 1
- Often first- or second-choice for specific indications but require careful monitoring 1
- Generally associated with more adverse events and higher cost 1
Reserve Group (Red Light)
- Last-resort options for multidrug-resistant organisms (MDROs) 1
- Only eight antibiotics identified in this category 1
- Should be used exclusively for confirmed or suspected infections when other alternatives have failed 1
- Show consistent activity against organisms resistant to first- and second-choice options 1
- Major targets for antimicrobial stewardship programs with mandatory monitoring 1
Clinical Selection Framework
First-Choice Antibiotics
- Usually narrow-spectrum agents with benefits outweighing risks 1
- Relatively low levels of reported resistance 1
- Preferred initial empiric therapy for specific indications 1
Second-Choice Antibiotics
- Generally broader-spectrum agents with higher resistance rates or less favorable risk-benefit ratios 1
- Used when first-choice options are inadequate or contraindicated 1
Important caveat: The first/second-choice level and AWaRe categories are independent systems—a Watch antibiotic may be first-choice for certain infections 1
Mechanism of Action Classification
Antibiotics are traditionally organized by their cellular targets 2, 3:
Cell Wall Inhibitors
- β-lactams (penicillins, cephalosporins, carbapenems, monobactams) interfere with bacterial cell wall biosynthesis 4, 5
- Differ in stability to β-lactamases and antimicrobial spectrum 4
Protein Synthesis Inhibitors
Nucleic Acid Inhibitors
- Fluoroquinolones inhibit DNA gyrase and topoisomerase IV, preventing DNA replication, transcription, repair, and recombination 6
- Different mechanism from β-lactams, aminoglycosides, and macrolides, allowing activity against bacteria resistant to those classes 6, 7, 6
Membrane-Active Antibiotics
- Disrupt bacterial cell membrane integrity 3
Susceptibility Classification
Bacteria are categorized based on laboratory testing 1:
Susceptible (S)
- Pathogen likely inhibited if antimicrobial reaches usual achievable blood concentrations 1
- Defined by minimum inhibitory concentration (MIC) breakpoints 1
Intermediate (I)
- Variable response to therapy; may respond if drug is concentrated at infection site or dosage increased 1
- Provides technical buffer zone preventing minor variations from causing interpretation errors 1
Resistant (R)
- Microbiological resistance: Organisms possess resistance mechanisms demonstrated phenotypically or genotypically 1
- Clinical resistance: Infection highly unlikely to respond even to maximum antibiotic doses 1
- May be qualified as low-level, moderate, or high-level resistance 1
Spectrum Classification
Antibiotics are characterized by their range of activity 1:
- Gram-positive, Gram-negative, aerobic, facultatively anaerobic, or obligate anaerobes 1
- Acquired resistance alters spectrum patterns over time and location 1
Cross-Resistance Patterns
- Complete or partial insusceptibility to antibiotic groups 1
- Strictly applies to same chemical class (e.g., β-lactams, aminoglycosides, macrolides) 1
- Resistance mechanisms like impermeability or efflux may affect multiple classes (associated resistance) 1
Clinical pitfall: Fluoroquinolone resistance develops slowly through multiple mutations (10⁻⁹ to 10⁻¹⁰ frequency), with cross-resistance between fluoroquinolones but not with other antibiotic classes 6